PF-Atlas › Clinical Trials › NCT04702893
INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
Nintedanib · Not specified
Registry ID
NCT04702893
Phase
Not specified
Status
Completed
Drug / intervention
Nintedanib
Sponsor
Boehringer Ingelheim
Start
2021-05-28
About this trial
Nintedanib is evaluated in NCT04702893, a idiopathic pulmonary fibrosis study sponsored by Boehringer Ingelheim. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04702893 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.